These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17205558)

  • 1. Early histologic changes in fibrosing cholestatic hepatitis C.
    Dixon LR; Crawford JM
    Liver Transpl; 2007 Feb; 13(2):219-26. PubMed ID: 17205558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of clinical parameters when differentiating cholestatic hepatitis C virus from allograft rejection.
    Neff GW; Shire N; Ruiz P; O'Brien C; Garcia M; Dela Garza J; Rudich SR; Reddy KR
    Transplant Proc; 2005 Dec; 37(10):4397-402. PubMed ID: 16387130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of acidophil bodies in the diagnosis of recurrent hepatitis C infection after orthotopic liver transplantation.
    Saxena R; Crawford JM; Navarro VJ; Friedman AL; Robert ME
    Mod Pathol; 2002 Sep; 15(9):897-903. PubMed ID: 12218206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transplant recurrent hepatitis C: immunohistochemical detection of hepatitis C virus core antigen and possible pathogenic implications.
    Pessôa MG; Alves VA; Wakamatsu A; Gomes JG; Maertens G; van der Borght B; Kim M; Ferrell L; Wright TL
    Liver Int; 2008 Jul; 28(6):807-13. PubMed ID: 18422936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrosing cholestatic hepatitis-like syndrome in a hepatitis B virus and hepatitis C virus-negative renal transplant recipient: a case report with autopsy findings.
    Duseja A; Nada R; Kalra N; Acharya SK; Minz M; Joshi K; Chawla Y
    Trop Gastroenterol; 2003; 24(1):31-4. PubMed ID: 12974214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperbilirubinemia and cholestatic liver injury in hepatitis C-infected liver transplant recipients.
    Cotler SJ; Taylor SL; Gretch DR; Bronner MP; Rizk R; Perkins JD; Carithers RL
    Am J Gastroenterol; 2000 Mar; 95(3):753-9. PubMed ID: 10710070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and histological features of fibrosing cholestatic hepatitis].
    Zhu Y; Luo K; Yu L
    Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):434-6. PubMed ID: 12502446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapidly progressive fibrosing cholestatic hepatitis--hepatitis C virus in HIV coinfection.
    Rosenberg PM; Farrell JJ; Abraczinskas DR; Graeme-Cook FM; Dienstag JL; Chung RT
    Am J Gastroenterol; 2002 Feb; 97(2):478-83. PubMed ID: 11866292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
    Rayhill SC; Wu YM; Katz DA; Voigt MD; Labrecque DR; Kirby PA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Schmidt WN
    Transplantation; 2007 Aug; 84(3):331-9. PubMed ID: 17700157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests.
    Abraham SC; Poterucha JJ; Rosen CB; Demetris AJ; Krasinskas AM
    Am J Surg Pathol; 2008 Jul; 32(7):965-73. PubMed ID: 18460980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation.
    Gawrieh S; Papouchado BG; Burgart LJ; Kobayashi S; Charlton MR; Gores GJ
    Liver Transpl; 2005 Oct; 11(10):1207-13. PubMed ID: 16184568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of recurrent hepatitis C after liver transplantation in a recent cohort of patients.
    Khettry U; Huang WY; Simpson MA; Pomfret EA; Pomposelli JJ; Lewis WD; Jenkins RL; Gordon FD
    Hum Pathol; 2007 Mar; 38(3):443-52. PubMed ID: 17188331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of central perivenulitis in pediatric liver transplantation.
    Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT
    Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis.
    Samonakis DN; Cholongitas E; Thalheimer U; Kalambokis G; Quaglia A; Triantos CK; Mela M; Manousou P; Senzolo M; Dhillon AP; Patch D; Burroughs AK
    Liver Transpl; 2007 Sep; 13(9):1305-11. PubMed ID: 17763383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation.
    Yilmaz N; Shiffman ML; Stravitz RT; Sterling RK; Luketic VA; Sanyal AJ; Mills AS; Contos MJ; Coterell A; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2007 Jul; 13(7):975-83. PubMed ID: 17600360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphologic features of hepatitis C recurrence in patients after orthotopic liver transplantation-preliminary analysis of our case observations.
    Ziarkiewicz-Wróblewska B; Górnicka B; Ołdakowska-Jedynak U; Bogdańska M; Wróblewski T; Morton M; Ziółkowski J; Paczek L; Krawczyk M; Wasiutyński A
    Transplant Proc; 2006; 38(1):226-30. PubMed ID: 16504709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fulminant hepatic failure in a renal transplant recipient with positive hepatitis B surface antigens: a case report of fibrosing cholestatic hepatitis.
    Hung YB; Liang JT; Chu JS; Chen KM; Lee CS
    Hepatogastroenterology; 1995; 42(6):913-8. PubMed ID: 8847045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation.
    Pessoa MG; Bzowej N; Berenguer M; Phung Y; Kim M; Ferrell L; Hassoba H; Wright TL
    Hepatology; 1999 Dec; 30(6):1513-20. PubMed ID: 10573532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation.
    Hanouneh IA; Feldstein AE; McCullough AJ; Miller C; Aucejo F; Yerian L; Lopez R; Zein NN
    Liver Transpl; 2008 Sep; 14(9):1287-93. PubMed ID: 18756451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.